Cindy Leissinger

6.4k citations

103 papers · 2.6k indexed · h-index 28

Hematology top 0.5%
Genetics top 2%
Surgery top 10%
Epidemiology top 10%
Cardiology and Cardiovascular Medicine top 10%

Co-authors: W. Keith Hoots Bruce M. Ewenstein Rebecca Kruse‐Jarres Philip M. Blatt Joan Cox Gill Craig M. Kessler Peter W. Collins Christine L. Kempton
Topics: Hemophilia Treatment and Research (76 papers)Platelet Disorders and Treatments (42 papers)Blood Coagulation and Thrombosis Mechanisms (22 papers)
Cited by: Hematology Genetics Internal Medicine
Journals: New England Journal of Medicine Journal of Clinical Investigation Journal of Clinical Oncology
Partner nations: United States Italy Canada

In The Last Decade

Cindy Leissinger

99 papers receiving 2.5k citations

Peers

Countries citing papers authored by Cindy Leissinger

Since Specialization

Citations

This map shows the geographic impact of Cindy Leissinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Leissinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Leissinger more than expected).

Fields of papers citing papers by Cindy Leissinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Leissinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Leissinger. The network helps show where Cindy Leissinger may publish in the future.

Co-authorship network of co-authors of Cindy Leissinger

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Leissinger. A scholar is included among the top collaborators of Cindy Leissinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Leissinger. Cindy Leissinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk 2024 ·Journal of Thrombosis and Haemostasis ·Pooja Vir,(unknown),Batsukh Dorjbal,Dennis P. McDaniel,Atul Agrawal,Elizabeth P. Merricks,Margaret V. Ragni,Cindy Leissinger,(unknown),Kenneth Lieuw,Timothy C. Nichols,Kathleen P. Pratt	0
2	Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life 2022 ·Journal of the Advanced Practitioner in Oncology ·Miguel A. Escobar,Cindy Leissinger,Guy Young	2
3	B cell–activating factor modulates the factor VIII immune response in hemophilia A 2021 ·Journal of Clinical Investigation ·Bhavya S. Doshi,(unknown),Giancarlo Castaman,(unknown),Radosław Kaczmarek,John S. Butterfield,Shannon L. Meeks,Cindy Leissinger,Moanaro Biswas,Valder R. Arruda	17
4	Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery 2016 ·Thrombosis and Haemostasis ·Tyler W. Buckner,Andrew D. Leavitt,Margaret V. Ragni,Christine L. Kempton,M. Elaine Eyster,Adam Cuker,Steven R. Lentz,Jonathan M. Ducore,Cindy Leissinger,Mike Wang,Nigel S. Key	28
5	Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening 2015 ·American Journal of Hematology ·Connie H. Miller,(unknown),Brian Boylan,Amanda B. Payne,F. M. Kelly,Miguel A. Escobar,Joan Cox Gill,Cindy Leissinger,J. Michael Soucie	7
6	Advances in the clinical management of inhibitors in hemophilia A and B 2015 ·Seminars in Hematology ·Cindy Leissinger	16
7	Rituximab for treatment of inhibitors in haemophilia A 2014 ·Thrombosis and Haemostasis ·Cindy Leissinger,Cassandra D. Josephson,Barbara A. Konkle,(unknown),Margaret V. Ragni,Janna M. Journeycake,Leonard A. Valentino,Nigel S. Key,Joan Cox Gill,Keith R. McCrae,Ellis J. Neufeld,(unknown),Leslie Raffini,(unknown),(unknown),Victor J. Marder,Carolyn M. Bennett,Susan F. Assmann,Suzanne Granger	35
8	Assessing the impact of age, race, ethnicity and inhibitor status on functional limitations of patients with severe and moderately severe haemophilia A 2011 ·Haemophilia ·Cindy Leissinger,David L. Cooper,Caitlyn T. Solem,(unknown)	26
9	PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A Patients 2011 ·Value in Health ·Hyunji Jo,A. Gringeri,Cindy Leissinger,LG Mantovani,Paolo Angelo Cortesi,E. Gemmen	1
10	Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A 2008 ·Expert Opinion on Biological Therapy ·(unknown),Brian Barnett,Cindy Leissinger	3
11	Emergency Department Care for Patients with Hemophilia and Von Willebrand Disease 2008 ·Journal of Emergency Medicine ·(unknown),Rebecca Kruse‐Jarres,Cindy Leissinger	34
12	Current management of acquired factor VIII inhibitors 2008 ·Current Opinion in Hematology ·Brian Barnett,Rebecca Kruse‐Jarres,Cindy Leissinger	18
13	Inhibitor development and successful immune tolerance in an HIV‐infected patient with haemophilia A and after immune reconstitution with HAART 2007 ·Haemophilia ·(unknown),(unknown),Cindy Leissinger	1
14	Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference 2006 ·Haemophilia ·Erik Berntorp,(unknown),Jan Astermark,V. Blanchette,P. Collins,Donna DiMichele,Carmen Escuriola,C. R. M. Hay,W. Keith Hoots,Cindy Leissinger,Claude Négrier,Johannes Oldenburg,K. Peerlinck,Mark T. Reding,Carol S. Hart	82
15	Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera 2005 ·Virology Journal ·Scott A. Tenenbaum,Cindy A. Morris,Steve S. Alexander,Harris E. McFerrin,Robert F. Garry,Cindy Leissinger	9
16	Pharmacokinetic analysis of plasma‐derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B 2002 ·Transfusion ·Bruce M. Ewenstein,J. Heinrich Joist,Amy D. Shapiro,Thomas Hofstra,Cindy Leissinger,Stephanie Seremetis,Martin I. Broder,Guenther Mueller‐Velten,Bruce A. Schwartz,(unknown)	85
17	High‐dose DDAVP intranasal spray (Stimate^®) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A 2001 ·Haemophilia ·Cindy Leissinger,David L. Becton,(unknown),Joan Cox Gill	73
18	Concurrence of anaphylaxis and acute heparin-induced thrombocytopenia in a patient with heparin-induced antibodies 1998 ·Journal of Vascular Surgery ·Robert L. Hewitt,Donald L. Akers,Cindy Leissinger,Javed Gill,Richard H. Aster	17
19	Unbound immunoglobulins are a major source of error in the quantitation of platelet surface‐bound immunoglobulin levels 1992 ·Transfusion ·Cindy Leissinger,W. J. Stuckey	3
20	Role of splenectomy in the management of hemophilic patients with human immunodeficiency virus‐associated immunopathic thrombocytopenic purpura 1992 ·American Journal of Hematology ·Cindy Leissinger,W. Abe Andes	8

About Cindy Leissinger

Cindy Leissinger is a scholar working on Hematology, Genetics and Internal Medicine, having authored 103 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (76 papers), Platelet Disorders and Treatments (42 papers) and Blood Coagulation and Thrombosis Mechanisms (22 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (549 citations) and Internal Medicine (183 citations). Cindy Leissinger has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include W. Keith Hoots, Bruce M. Ewenstein, Rebecca Kruse‐Jarres, Philip M. Blatt, Joan Cox Gill, Craig M. Kessler, Peter W. Collins, Christine L. Kempton, Andreas Tiede and Paul Knoebl. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact